{"entity":{"id":"idea-moon-hpv-vaccine-confidence","kind":"idea","name":"Community-tailored HPV vaccine confidence campaigns with school-based delivery","aka":[],"tldr":"The HPV vaccine prevents most cervical cancer, but false safety claims have cut uptake in several countries. Rebuild confidence locally and deliver the vaccine in schools.","summary":"HPV vaccination collapsed in Japan after unfounded safety concerns and has stalled in parts of Europe and the US; countries with school-based programmes and sustained trusted messaging (Australia, Scotland, Rwanda) achieve high coverage and are seeing dramatic falls in cervical disease. The proposal is a programme combining school-based single-dose delivery, community-specific confidence work through trusted messengers, and rapid response to local scares, with coverage tracked at district level.","asOf":"2026-09-08","links":[{"label":"Bottleneck evidence (Misinformation and unproven therapies): Johnson et al., Cancer misinformation and harmful information on Facebook and other social media (JNCI 2022)","url":"https://doi.org/10.1093/jnci/djab141"}],"tags":[],"related":[],"cancers":["cervical","head-and-neck"],"sections":[],"technologies":["hpv-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-misinformation","b-prevention-adoption"],"keyPapers":["paper-johnson-j-natl-cancer-inst"],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Tailored confidence campaigns with school delivery raise coverage above 80% in low-uptake districts within three years.","rationale":"Coverage differences between neighbouring countries with the same vaccine show that delivery model and trust, not biology, determine uptake.","test":"Cluster-randomised campaign rollout across low-uptake districts with coverage as the primary endpoint.","maturity":"being-tested-at-scale","actor":"policy","cost":"medium","horizonYears":3},"route":"/ideas/idea-moon-hpv-vaccine-confidence/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"}],"technology":[{"id":"hpv-vaccine","kind":"technology","name":"HPV & HBV vaccination","route":"/technologies/hpv-vaccine/"}],"bottleneck":[{"id":"b-misinformation","kind":"bottleneck","name":"Misinformation and unproven therapies","route":"/bottlenecks/b-misinformation/"},{"id":"b-prevention-adoption","kind":"bottleneck","name":"Prevention we already have is not deployed","route":"/bottlenecks/b-prevention-adoption/"}],"paper":[{"id":"paper-johnson-j-natl-cancer-inst","kind":"paper","name":"Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report","route":"/key-papers/paper-johnson-j-natl-cancer-inst/"},{"id":"paper-hpv-vaccine-sweden-nejm-2020","kind":"paper","name":"Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17","route":"/key-papers/paper-hpv-vaccine-sweden-nejm-2020/"}],"roadmap":[{"id":"prevention-roadmap","kind":"roadmap","name":"Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers","route":"/roadmaps/prevention-roadmap/"}]}}